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Graphical abstract synopsis 
(N-Ru-C)-cycloruthenates are easily prepared at room temperature on reaction of 
arylimines with [RuCl2(p-cymene)]2 and KOAc in methanol, via ortho arene C-H 
activation/deprotonation by acetate. The presence of a Ru-Cl remaining bond, instead 
of a Ru-OAc bond,  is crucial for compound isolation. This preparative method was 
applied to 2-phenyl oxazoline, benzo[h]quinoline, 2-phenylpyridine and 
1-phenylpyrazole derivatives.  
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Cycloruthenation of aryl imines and N-heteroaryl benzenes  
 via C-H bond activation with Ru(II) and acetate partners 
Bin Li,a,b Christophe Darcel,a* Thierry Roisnel, c Pierre H. Dixneufa*  
a
Institut des Sciences Chimiques de Rennes, UMR 6226 CNRS-Université de Rennes 1, 
Team “Organometallics: Materials and Catalysis” Centre for Catalysis and Green Chemistry,
Campus de Beaulieu, 35042 Rennes, France 
b
School of Chemical & Environmental Engineering, Wuyi University, Jiangmen 529020, Guangdong 
Province, P.R. China 
c
Institut des Sciences Chimiques de Rennes, UMR 6226 CNRS – Université de Rennes 1, Centre de 
Diffractométrie X, Campus de Beaulieu, 35042 Rennes, France. 
In the memory of professor Alexander Shilov  
for his creative and inspiring work on C-H bond activation 
Abstract. The reaction of arylimines with [RuCl2(p-cymene)]2 and 4 equiv. of KOAc at room 
temperature in methanol leads to the formation of N-Ru-C cycloruthenates 
RuCl(arylimine-kC,N)(p-cymene) 3a-3d via ortho C-H activation/deprotonation by acetate. 
The presence of the stable Ru-Cl bond rather than a labile Ru-OAc bond is crucial for the 
isolation of the complexes. This preparative method of cyclometallates was applied to 
2-phenyl oxazoline, and benzo[h]quinoline and to the improved synthesis of  
2-phenylpyridine and 1-phenylpyrazole derivatives. The molecular structures of three 
cycloruthenates are reported. 
Keywords: N-Ru-C cycloruthenates, C-H bond activation, C-H bond deprotonation, 
arylimines, ruthenium-acetate. 
1 Introduction 
Since the initial creative work of Alexander Shilov on C-H bond activation of alkanes with 
Pt(II) and Pt(IV) 1,2 catalysts leading especially to alcohols,2 many transition metal complexes 
have been shown to promote the activation of C-H bonds via various processes and to further 
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lead to catalytic functionalizations of aromatic systems and alkanes.3 Among these molecular 
metal catalysts, after the useful contribution of ruthenium(0) species in the Murai reaction,4
the easily prepared, inexpensive and stable ruthenium(II) complexes are now offering easy 
and diverse catalytic functionalizations of sp2 C-H 5,6 as well as sp3 C-H 7 bonds. 
Ruthenium(II)-catalyzed sp2C-H bond functionalization of functional aromatic 
compounds has known since 2001 a tremendous development due to the control of direct 
(hetero)arylation with aryl and heteroaryl halides for the preparation of polyfunctional 
molecules and polydentate ligands8-11 and for the access to polyfunctional alkenes via catalytic 
alkenylation.5,12 For catalytic functionalization of arene C-H bonds the mechanism based on 
kinetics was shown13,14 to be favoured by nitrogen containing functional/directing groups and 
to take place via an initial, easy ortho C-H bond deprotonation by carbonate only10a,11 or by 
carboxylate10b-10e as a proton shuttle to form a cyclometallated ruthenium(II) intermediate. 
The oxidative addition of arylhalide to the orthometallacycle followed by the reductive C-C 
bond formation is a more energy demanding step,13,14 that can be also performed in water as 
solvent.15
The first preparations of (N,C)-cyclometallated ruthenium(II) complexes were made by 
transmetallations from mercury salts.16 Then they were performed more directly by C-H bond 
deprotonation of N-containing functional arenes as reported by Pfeffer et al.17 and Davies et 
al..18 Thus the cyclometallated ruthenium(II) complexes arising from the deprotonation of 
arylmethylamines,16a,17a,b,e 1-aminotetralin,17f and N-containing heterocycles such as 
phenylpyrrolidine,17e phenylpyridine,11a,b,c,18a oxazolines,18c,d pyrazole18d were successfully 
isolated. By contrast the preparation of cycloruthenates of arylimines with ruthenium(II) 
complexes was not straightforward in spite of the easiness of their Ru(II)-catalyzed ortho 
arylations.19-21 Cationic ruthenium(II) cyclometallated benzylideneanilines PhC(R)=NPh (R = 
H, Me) were first obtained on reaction with RuCl2(PMe3)(C6Me6)/ 2AgBF4.
22 By contrast 
benzodiazepine reacted with [RuCl2(p-cymene)]2 and NEt3 to generate the (N,C)-ruthenacycle 
involving the benzodiazepine arylimine moiety.23
Davies18a showed that the acetate ligand of RuCl(OAc)(p-cymene) complex could 
promote the formation at room temperature of (N,C)-cyclometallated complexes from 
aldimines but only when they contained a N-alkyl group and in the presence of an excess of  
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benzaldehyde.18 This methodology could not be used for the preparation of cyclometallated 
ruthenium(II) complexes from arylideneanilines,18d which easily led by contrast to their 
rhodium and iridium cyclometallated derivatives. For the later  the regioselectivity of C-H 
bond deprotonation was shown to be mostly sensitive to steric effects.18a,18b,24
Orthometallation of aryloxazolines appeared less favorable than that of alkylimines. It 
occurred only with iridium complexes and not with ruthenium or rhodium derivatives. 18d
The ruthenium(II) catalyzed direct ortho C-H bond diarylations of N-arylimines with 
arylhalides by action of both acetate and PPh3 ligands were successfully performed in NMP,
20
and more surprisingly in water with higher activity of the catalyst. 21 The first step of this 
reaction is expected to be the formation of the orthometallated intermediate via the C-H bond 
deprotonation, which motivated the search for the conditions to form and isolate the N-aryl 
imine cycloruthenation intermediates. 
We now describe the general and facile access to a variety of cyclometallated ruthenium(II) 
complexes first of arylimines, following our preliminary report,25 on reaction with 
[RuCl2(p-cymene)]2 at room temperature in the presence of KOAc in methanol. It will be 
shown that these complexes are stable when a Ru-Cl bond is retained. This ortho C-H bond 
activation by deprotonation with acetate can be applied to functional arenes equipped of  a 
nitrogen-containing heterocyclic directing group such as pyridine, pyrazole, oxazoline and 
benzo[h]quinoline and three of these cyclometallate complexes are characterized by X-ray 
structure analysis.  
2 Experimental  
2.1 General  
All reagents were obtained from commercial sources and used as received. THF and 
dichloromethane were dried over Braun MB-SPS-800 solvent purification system, and stored 
under an argon atmosphere. Methanol (anhydrous, HPLC grade, Aldrich) was used as 
received. Technical grade petroleum ether (40-60 °C b.p.) and ethyl acetate were used for 
chromatography column. Analytical TLC was performed on Merck 60F254 silica gel plates 
(0.25 mm thickness). Column chromatography was performed on Acros Organics Ultrapure 
silica gel (mesh size 40-60µm, 60A). 
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1H NMR spectra were recorded in CDCl3 at ambient temperature on Bruker DPX-200, 
AVANCE I 300, AVANCE III 400 spectrometers at 200.1, 300.1 and 400.1 MHz, using the 
solvent as the internal standard (CDCl3, 7.26 ppm). 
13C NMR spectra were obtained at 50, 75 
and 100 MHz and referenced to the internal solvent signals (CDCl3, central peak at 77.2 ppm). 
Chemical shift () and coupling constants (J) are given in ppm and in Hz, respectively. The 
peak patterns are indicated as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet, 
and br. for broad. Infrared spectra were recorded on a Bruker IFS28 spectrometer using KBr 
pellets. HRMS were measured on Waters Q-TOF 2, at the CRMPO (Centre régional de 
mesures physiques de l'Ouest), Université de Rennes 1.
2.2 General procedures for the reactions of imines with [RuCl2(p-cymene)]2 
[RuCl2(p-cymene)]2 (0.1 mmol, 61.2 mg), imine (0.2 mmol), KOAc (0.4 mmol, 40 mg) and 
methanol (5 mL) were introduced in a dried Schlenck tube under argon, equipped with 
magnetic stirring bar and the mixture was stirred at ambient temperature for 20 h. The solvent 
was then evaporated under vacuum and the desired product was purified by chromatography 
column on silica gel (0.5 mol% Et3N) with a mixture of petrol ether/ethyl acetate as the 
eluent.  
[RuCl{C6H4-1-C(H)=N(4-CH3C6H4-kC,N)}(p-cymene)] (3a) 
This compound was prepared from the imine 2a. The complex 3a was purified by 
chromatography column on silica gel with a mixture of petroleum ether/ethyl acetate as the 
eluent (75:25), and was isolated as a orange solid (83 mg, 90 %). Rf  (petroleum ether/EtOAc 
70:30) = 0.45.  
1
H NMR (400 MHz, CDCl3):  = 8.20 (d, 1H, J = 7.6 Hz, H6), 8.10 (s, 1H, H7), 7.66 (d, 2H, J
= 8.4 Hz, H11), 7.54 (d, 1H, J = 7.6 Hz, H3), 7.23-7.17 (m, 3H, H10, H4 or H5), 7.02 (t, 1H, J = 
7.4 Hz, H4 or H5), 5.48 (d, 1H, J = 6.0 Hz, cymene), 5.22 (d, 1H, J = 6.0 Hz, cymene), 4.87 (d, 
1H, J = 6 Hz, cymene), 4.83 (d, 1H, J = 6.0 Hz, cymene), 2.43-2.36 (m, 4H, H13, CHMeMe’), 
2.08 (s, 3H, Me cymene), 0.99 (d, 3H, J = 6.8 Hz, CHMeMe’), 0.85 (d, 3H, J = 6.8 Hz, 
CHMeMe’). The protons H3, H6, H10 have been assigned from a COSY experiment.
13
C{
1
H} 
NMR (100 MHz, CDCl3):  =189.2 (C-Ru), 171.7, 152.8, 146.2, 139.3, 137.3, 130.3, 129.8, 
129.4, 122.6, 122.3, 102.5, 100.7, 92.7, 89.6, 82.9, 82.4, 31.0, 23.1, 21.6, 21.3, 18.9. IR: v
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(C=N) 1579 cm-1. HRMS (ESI): m/z calcd for C24H26N
35ClNa102Ru [M+ Na]+ 488.0695, 
found 488.0708. m/z calcd for C24H26N
102Ru [M- Cl]+ 430.1109, found 430.1112.
[RuCl{(4-OMeC6H4)-1-C(H)=N(4-CH3C6H4-kC,N)}(p-cymene)] (3b)
This compound was prepared from the imine 2b (45 mg, 0.2 mmol). The complex 3b was 
purified by chromatography column on silica gel with a mixture of petroleum ether/ethyl 
acetate as the eluent (70:30), and was isolated as a red solid (77 mg, 77 %). Rf  (petroleum 
ether/EtOAc 70:30) = 0.30.  
1
H NMR (300 MHz, CDCl3):  = 7.97 (s, 1H, H7), 7.72 (d, 1H, J = 2.4 Hz, H6), 7.63 (d, 2H, J
= 8.4 Hz, H11), 7.48 (d, 1H, J = 8.4 Hz, H3), 7.19 (d, 2H, J = 8.4 Hz, H10), 6.56 (dd, 1H, J = 
2.4 Hz, J = 8.4 Hz, H4), 5.44 (d, 1H, J = 6.0 Hz, cymene), 5.18 (d, 1H, J = 5.7 Hz, cymene), 
4.83 (m, 2H, cymene), 3.92 (s, 3H, OMe), 2.41-2.35 (m, 4H, H13, CHMeMe’), 2.08 (s, 3H, 
Me cymene), 0.99 (d, 3H, J = 6.9 Hz, CHMeMe’), 0.85 (d, 3H, J = 6.9 Hz, CHMeMe’). 
13
C{
1
H} NMR (75 MHz, CDCl3):  =191.5 (C-Ru), 170.2, 160.3, 152.8, 139.7, 136.8, 131.1, 
129.3, 123.6, 122.3, 109.0, 102.3, 100.1, 92.4, 89.2, 83.0, 82.2, 55.3, 30.9, 23.1, 21.6, 21.2, 
18.9. IR: v (C=N) 1582 cm-1. HRMS (ESI): m/z calcd for C25H28NO
35ClNa102Ru [M+ Na]+
518.0801, found 518.0817. m/z calcd for C25H28NO
102Ru [M- Cl]+ 460.1214, found 460.1212. 
[RuCl{(4-ClC6H4)-1-C(H)=N(4-CH3C6H4-kC,N)}(p-cymene)] (3c) 
This compound was prepared from the imine 2c (45.8 mg, 0.2 mmol). The complex 3c was 
purified by chromatography column on silica gel with a mixture of petroleum ether/ethyl 
acetate as the eluent (75:25), and was isolated as a red solid (52 mg, 52 %). Rf  (petroleum 
ether/EtOAc 70:30) = 0.65.  
1
H NMR (300 MHz, CDCl3):  = 8.15 (d, 1H, J = 1.8 Hz, H6), 8.06 (s, 1H, H7), 7.63 (d, 2H, J
= 8.1 Hz, H11), 7.45 (d, 1H, J = 7.8 Hz, H3), 7.22 (d, 2H, J = 8.1 Hz, H10), 7.01-6.97 (m, 1H, 
H4), 5.47 (d, 1H, J = 6.0 Hz, cymene), 5.22 (d, 1H, J = 6.0 Hz, cymene), 4.90 (d, 1H, J = 6.0 
Hz, cymene), 4.85 (d, 1H, J = 6.0 Hz, cymene), 2.42-2.33 (m, 4H, H13, CHMeMe’), 2.10 (s, 
3H, Me cymene), 0.98 (d, 3H, J = 6.9 Hz, CHMeMe’), 0.85 (d, 3H, J = 6.9 Hz, CHMeMe’). 
13
C{
1
H} NMR (75 MHz, CDCl3):  =190.5 (C-Ru), 170.8, 152.5, 144.5, 138.5, 137.6, 136.0, 
130.4, 129.5, 123.0, 122.2, 103.1, 100.9, 92.9, 89.4, 83.7, 82.6, 31.0, 23.0, 21.7, 21.3, 19.0. IR: 
v (C=N) 1578 cm-1. HRMS (ESI): m/z calcd for C24H25N
35Cl2Na
102Ru [M+ Na]+ 522.0305, 
found 522.0323. m/z calcd for C24H25 N
35Cl 102Ru [M- Cl]+ 464.0719, found 464.0719. 
[RuCl{C6H4-1-C(CH3)=N(4-OCH3C6H4-kC,N)}(p-cymene)] (3d) 
This compound was prepared from the imine 2d (45 mg, 0.2 mmol). The complex 3d was 
purified by chromatography column on silica gel with a mixture of petroleum ether/ethyl 
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acetate (70:30) as the eluent, and was isolated as a red solid (72 mg, 73 %). Rf  (petroleum 
ether/EtOAc 70:30) = 0.35  
1
H NMR (300 MHz, CDCl3):  = 8.20 (d, 1H, J = 7.5 Hz, H3 or H6), 7.46 (d, 1H, J = 7.5 Hz, 
H3 or H6), 7.30-7.18 (m, 3H, H11, H4 or H5), 7.05-6.96 (m, 3H, H10, H4 or H5), 5.33 (d, 1H, J = 
6.0 Hz, cymene), 4.95 (d, 1H, J = 6.0 Hz, cymene), 4.63 (d, 2H, J = 6.0 Hz, cymene), 3.91 (s, 
3H, OMe), 2.57-2.48 (m, 1H, CHMeMe’), 2.27 (s, 3H, H14), 2.02 (s, 3H, Me cymene), 1.01 (d, 
3H, J = 6.9 Hz, CHMeMe’), 0.83 (d, 3H, J = 6.9 Hz, CHMeMe’). 13C{1H} NMR (100 MHz, 
CDCl3):  =188.3 (C-Ru), 179.6, 157.8, 147.4, 146.4, 139.3, 130.1, 128.3, 121.9, 116.5, 114.8, 
102.9, 102.6, 92.8, 90.4, 80.3, 80.2, 55.6, 30.8, 23.0, 21.3, 18.8, 16.9. IR: v (C=N) 1578 cm-1. 
HRMS (ESI): m/z calcd for C25H28NO
35ClNa102Ru [M+ Na]+ 518.0801, found 518.0811. m/z 
calcd for C25H28NO
 102Ru [M- Cl]+ 460.1214, found 460.1211.
2.3 Reaction of 2-phenyl-2-oxazoline with [RuCl2(p-cymene)]2: preparation of complex 5. 
This compound was prepared from 2-phenyl-2-oxazoline 4 (0.2 mmol, 26.3 µL). The desired 
complex 5 was purified by chromatography column on silica gel with a mixture of petroleum 
ether/ethyl acetate (30:70) as the eluent, and was isolated as a green solid (32.7 mg, 40%). Rf  
(petroleum ether/EtOAc 30:70) = 0.25  
1
H NMR (300 MHz, CDCl3):  = 8.15 (d, 1H, J = 7.5 Hz, H3 or H6), 7.35 (d, 1H, J = 7.5 Hz, 
H3 or H6), 7.22 (t, 1H, J = 7.5 Hz, H4 or H5), 6.98 (t, 1H, J = 7.5 Hz, H4 or H5), 5.56 (d, 1H, J
= 5.7 Hz, cymene), 5.46 (d, 1H, J = 5.7 Hz, cymene), 5.19 (d, 1H, J = 5.7 Hz, cymene), 4.99 
(d, 1H, J = 5.7 Hz, cymene), 4.78-4.67 (m, 2H, H11), 4.26-4.08 (m, 2H, H10), 2.55 (sept, 1H, J
= 6.9 Hz,  CHMeMe’), 2.06 (s, 3H, Me cymene), 1.10 (d, 3H, J = 6.9 Hz, CHMeMe’), 1.00 
(d, 3H, J = 6.9 Hz, CHMeMe’). 13C{1H} NMR (75 MHz, CDCl3):  = 182.7 (C-Ru), 174.2, 
139.3, 130.9, 130.7, 126.4, 122.3, 101.3, 99.3, 88.1, 87.5, 81.8, 81.0, 70.8, 54.4, 31.2, 22.8, 
22.2, 19.1. IR: v (C=N) 1632 cm-1. HRMS (ESI): m/z calcd for C19H22NO
35ClNa102Ru [M+ 
Na]+ 440.0331, found 440.0336; m/z calcd for C19H22NO
 102Ru [M- Cl]+ 382.0745, found 
482.0755.
2.4 Reaction of benzo[h]quinoline with [RuCl2(p-cymene)]2 : preparation of complex 7. 
This compound was prepared from benzo[h]quinolone 6 (0.2 mmol, 35.8 mg). The desired 
complex 7 was purified by chromatography column on silica gel with a mixture of petroleum 
ether/ethyl acetate (50:50) as the eluent, and was isolated as a dark green solid (41.9 mg, 
47 %). Rf  (petroleum ether/EtOAc 1:1) = 0.20.  
1
H NMR (300 MHz, CDCl3):  = 9.48 (d, 1H, J = 5.1 Hz, H2), 8.41 (d, 1H, J = 6.9 Hz), 8.18 
(d, 1H, J = 7.8 Hz), 7.78 (d, 1H, J = 8.7 Hz), 7.63-7.42 (m, 4H), 5.74 (d, 1H, J = 5.7 Hz, 
cymene), 5.66 (d, 1H, J = 6.0 Hz, cymene), 5.30 (d, 1H, J = 6.0 Hz, cymene), 5.13 (d, 1H, J = 
6.0 Hz, cymene), 2.50 (m, 1H, CHMeMe’), 2.04 (s, 3H, Me cymene), 0.97 (d, 3H, J = 6.9 Hz, 
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CHMeMe’), 0.84 (d, 3H, J = 6.9 Hz, CHMeMe’). 13C{1H} NMR (75 MHz, CDCl3):  =178.4 
(C-Ru), 155.3, 152.5, 140.5, 136.6, 135.4, 133.9, 129.7, 129.3, 126.9, 122.8, 121.1, 120.9, 
101.5, 99.6, 89.7, 89.3, 83.6, 82.5, 30.9, 22.7, 21.8, 18.9. HRMS (ESI): m/z calcd for 
C23H22N
35ClNa102Ru [M+ Na]+ 472.0382, found 472.0390. m/z calcd for C23H22N
102Ru [M- 
Cl]+ 414.0796, found 414.0797. 
2.5 Reaction of 2-Phenylpyridine with [RuCl2(p-cymene)]2 : preparation of complex 9.
[13, 
18b]
This compound was prepared from 2-phenylpyridine 8 (0.2 mmol, 29 µL). The desired 
complex 9 was purified by chromatography column on silica gel with a mixture of petroleum 
ether/ethyl acetate (30/70) as the eluent, and isolated as a dark green solid (81 mg, 94 %). Rf  
(petroleum ether/EtOAc 30:70) = 0.35.  
1
H NMR (400 MHz, CDCl3):  = 9.16 (d, 1H, J = 5.2 Hz, H12), 8.09 (d, 1H, J = 7.6 Hz, H3), 
7.65-7.53 (m, 3H, H9, H10, H6), 7.11 (t, 1H, J = 7.2 Hz, J = 7.2 Hz, H4), 6.99-6.94 (m, 2H, H5, 
H11), 5.52-5.48 (m, 2H, cymene), 5.10 (d, 1H, J = 5.6 Hz, cymene), 4.91 (d, 1H, J = 5.6 Hz, 
cymene), 2.37 (sept, 1H, J = 6.8 Hz, CHMeMe’), 1.98 (s, 3H, Me cymene), 0.91 (d, 3H, J = 
6.8 Hz, CHMeMe’), 0.81 (d, 3H, J = 6.8 Hz, CHMeMe’). 13C{1H} NMR (100 MHz, CDCl3): 
 = 181.5 (C-Ru), 165.4, 154.7, 143.5, 139.7, 136.7, 129.5, 124.0, 122.6, 121.5, 118.9, 100.8, 
100.6, 90.9, 89.7, 84.3, 82.3, 30.9, 22.6, 21.8, 18.9. 
2.6 Reaction of 1-phenyl-1H-pyrazole with [RuCl2(p-cymene)]2 : preparation of complex 
11.
[18d]
This compound was prepared from 1-phenyl-1H-pyrazole (0.2 mmol, 26.4 µL). The desired 
complex 10 was purified by chromatography column on silica gel with a mixture of petroleum 
ether/ethyl acetate (30:70) as the eluent, and was isolated as a greenish solid (65.0 mg, 79 %) 
Rf (petroleum ether/EtOAc 30:70) = 0.40. 
1
H NMR (300 MHz, CDCl3):  = 8.15 (d, 1H, J = 7.2 Hz, H6), 8.06 (d, 1H, J = 2.1 Hz, H11), 
7.91 (d, 1H, J = 2.7 Hz, H9), 7.19-7.01 (m, 3H, H3, H4, H5), 6.47 (t, 1H, J = 2.7 Hz, H10), 5.57 
(d, 2H, J = 6.0 Hz, cymene), 5.30 (d, 1H, J = 6.0 Hz, cymene), 5.09 (d, 1H, J = 6.0 Hz, 
cymene), 2.47-2.44 (sept, 1H, J = 6.9 Hz, CHMeMe’), 2.06 (s, 3H, Me cymene), 0.97 (d, 3H, 
J = 6.9 Hz, CHMeMe’), 0.93 (d, 3H, J = 6.9 Hz, CHMeMe’). 13C{1H} NMR (75 MHz, 
CDCl3):  = 161.9 (C-Ru), 142.2, 141.9, 140.2, 126.1, 125.0, 123.2, 111.5, 108.4, 100.09, 
100.08, 88.7, 88.2, 84.2, 82.2, 30.7, 22.5, 22.0, 18.9. 
2.7 Preparation of complex 12
[RuCl2(p-cymene)]2 (0.1 mmol, 61.2 mg), 1-phenyl-1H-pyrazole (0.2 mmol, 26.4 µL), 
diphenylacetylene (0.2 mmol, 35.6 mg), KOAc (0.4 mmol, 40 mg) and methanol (5 mL) were 
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introduced in a dried Schlenck tube under Argon, equipped with magnetic stirring bar and was 
stirred at ambient temperature for 20 h. The solvent was then evaporated under vacuum and 
the desired product was purified by chromatography column on silica gel with a mixture of 
petrol ether/ethyl acetate (1:1) as the eluent. The complex 1218e was isolated as a dark green 
solid in 67% (79.3 mg).  
1
H NMR (300 MHz, CDCl3):  = 8.59 (d, 1H, J = 1.5 Hz, H11), 7.88 (d, 1H, J = 1.5 Hz, H9), 
7.39-7.14 (m, 7H), 6.97-6.87 (m, 4H), 6.81-6.74 (m, 3H), 6.52 (t, 1H, J = 2.4 Hz, H10), 5.57 
(d, 1H, J = 5.1 Hz, cymene), 4.66 (d, 1H, J = 5.1 Hz, cymene), 4.52 (d, 1H, J = 5.1 Hz, 
cymene), 3.51 (d, 1H, J = 5.1 Hz, cymene), 2.83 (sept, J = 6.9 Hz,1H, CHMeMe’), 2.47 (s, 
3H, Me cymene), 1.25 (d, 3H, J = 6.9 Hz, CHMeMe’), 1.10 (d, 3H, J = 6.9 Hz, 
CHMeMe’).13C{1H} NMR (75 MHz, CDCl3):  =183.3 (C-Ru), 152.5, 146.7, 146.0, 144.1, 
137.7, 137.5, 133.7, 133.4, 131.6, 128.5, 128.2, 127.2, 126.3, 125.9, 125.5, 124.7, 123.1, 
110.3, 107.8, 103.8, 96.4, 81.1, 78.9, 75.3, 31.4, 23.6, 23.2, 19.6. 
2.8 Catalytic arylation of imine 2a with Ru(II)-OAc catalytic system in NMP 
[RuCl2(p-cymene)]2 (0.025 mmol, 15.3 mg), KOAc (0.1 mmol, 10 mg) and K2CO3 (1.5 mmol, 
208 mg) were introduced in a dried Schlenck tube under argon, equipped with magnetic 
stirring bar. Imine 2a (0.5 mmol), phenylbromide (1.25 mmol), NMP (2 mL) and tetradecane 
(10 L) as the internal standard for gas chromatography, were added in the Schlenck tube 
which was then placed in the oil bath at 160 oC. The reaction mixture was stirred for the 
specified time. Then, the conversion of the reaction was analyzed by gas chromatography. The 
reaction mixture was diluted with 30 mL of diethyl ether, washed with water (20 mL × 3), and 
dried over MgSO4. The solvent was then evaporated under vacuum and the desired product 
was purified by chromatography using a silica gel column. The solvent was then evaporated 
under vacuum and the product was purified by chromatography using a silica gel column. The 
silica gel was previously stirred for 1h in 200 mL of petroleum ether containing 1 mol% Et3N 
(99:1). The products were eluted with a mixture of petroleum ether/ethyl acetate. The product 
was thus obtained and the mono and diarylated products ratio was determined by 1H NMR.  
N-[(o,o
’
-Diphenyl)benzylidene]-p-toluidine (14) 
Green solid, yield = 75%, 1H NMR (200 MHz, CDCl3):  = 8.36 (s, 1H), 7.61-7.40 (m, 13H), 
7.10 (d, 2H, J = 8.2 Hz), 6.62 (d, 2H, J = 8.1 Hz), 2.33 (s, 3H). 13C NMR (50 MHz, CDCl3):  
 = 161.0, 150.0, 143.0, 141.5, 135.7, 134.3, 130.5, 130.15, 129.9, 129.5, 128.5, 127.5, 120.60, 
21.38. GC: tR = 30.5 min. MS (EI): m/z: 346 (100, M
+ - H), 254 (16), 241 (15), 91 (10), 65 
(11); HRMS (ESI): m/z calcd for C26H21N (M+ H
+) 348.1746, found 348.1742. 
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2.8 X-ray crystallography 
Crystals of complexes 3a, 3b and 7 were mounted on Bruker APEX2 single crystal X-ray 
diffractometer using monochromated Mo K radiation ( = 0.71073Å). The structures were 
solved by direct methods using the program SHELXS-97 26. Refinement and all further 
calculations were carried out using SHELXL-97 27. The H-atoms were included in calculated 
positions and treated as riding atoms using the SHELXL default parameters. The non H atoms 
were refined anisotropically, using weighted full-matrix least-square on F2. Figures of 
complexes 3a, 3b and 7 were drawn with ORTEP. 
3 Results and discussion 
3.1 Synthesis of [RuCl(aryl imine)(p-cymene)] complexes 3a-3d 
The reaction of the [RuCl2(p-cymene)]2 complex 1 was first performed with 2 equivalents 
of aldimine 2a in the presence of various amounts of KOAc and K2CO3 in THF or methanol 
as an attempt to produce cyclometallated complex 3a. The choice of solvent is crucial as with 
2 equiv. of KOAc no transformation was observed in THF, but in methanol at room 
temperature 36% of complex 3a were formed. The increase to 4 equiv of KOAc led to the 
complete formation of the orange complex 3a which was isolated in 90% yield after 20h at 
room temperature (Scheme 1). It is noteworthy that the addition of K2CO3 disfavoured the 
formation of 3a and this is consistent with the kinetic studies of the reaction of 
Ru(OAc)2(arene) with 2-phenylpyridine
13 and 1-phenylpyrazole14 showing that the reaction  
was autocatalysed by the freed AcOH, and thus that the rate of ortho C-H bond activation was 
decreased by K2CO3. Only 10% yield of complex 3a was obtained in water as solvent likely 
due to the low solubility of the ruthenium complex 1 and substrates in water. The 
cycloruthenation of substituted aryl imines 2b-d with [RuCl2(p-cymene)]2 1 in methanol in 
the presence of 4 equiv. of KOAc at room temperature for 20 h led to the isolation of red 
complexes 3b (77%), 3c (52%), and 3d in 73% isolated yields (Scheme 1). The struture of 
3a-3d was based on 1H, 13C NMR and the X-ray struture analysis of compounds 3a and 3b.
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The ruthenium complex 3a, or its analogous derivative with a Ru-OAc bond instead of a 
Ru-Cl bond, was not detected in the reaction of Ru(OAc)2(p-cymene) and aryl imine 2a. 
However the unstable cyclometallate arising from the interaction of 2-phenyl pyridine with 
Ru(OAc)2(p-cymene) at 27°C in acetonitrile was observed.
13 Thus the aryl imine 2a was 
reacted with Ru(OAc)2(p-cymene) in methanol but in the presence of one equiv. of KCl and 
then 66% yield of the complex 3a was isolated (Scheme 2). This result shows that the 
complex 3a containing a Ru–Cl bond is more stable than its parent compound containing the 
Ru–OAc bond.  
This result, along with the formation of complexes 3a–3d from complex 1 or in situ 
formed Ru(OAc)2(p-cymene) complex, also shows that the Ru(II)-OAc bonds easily 
dissociate leading to free external anion OAc- which is able to deprotonate, on cooperative 
action of the Ru(II) centre, the neighbour ortho C-H bond of the substrate coordinated to this 
Ru(II) centre.13,14  
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3.2 Synthesis of [RuCl(N-containing heterocycle)(p-cymene)] complexes 5, 7, 9 and 11. 
The previous mild conditions for cyclometallation of aryl imines, with  [RuCl2(p-cymene)]2
in the presence of excess KOAc at room temperature, led us to apply this method for the 
synthesis and isolation of cycloruthenate complexes from arenes possessing a nitrogen 
containing heterocycle as directing group. Thus the heterocycle 2-phenyloxazoline 4 was 
reacted with [RuCl2(p-cymene)]2 in the presence of 4 equiv. of KOAc in methanol at room 
temperature and led to the formation of the green complex 
[RuCl(o-C6H4-2-oxazoline)(p-cymene)] 5, which was isolated in 40% (Scheme 3).  
The related complex with Ru-OAc bond was observed during the kinetic study of 
Ru(OAc)2(p-cymene) with the same oxazoline derivative 4 in acetonitrile,
14 which was shown 
not to be stable as it readily led to the dissociation of the Ru-OAc bond and to the formation 
of the complex [Ru(NCCD3)(o-C6H4-2-oxazoline)(p-cymene)]
+(AcO-) in the absence of 
choride anion and then to [Ru(NCCD3)4(o-C6H4-2-oxazoline)]
 +(AcO-) by displacement of the 
arene. 
The heterocycle benzo[h]quinoline 6 was also reacted with [RuCl2(p-cymene)]2 1 in 
methanol under the same conditions and afforded to the green cyclometallated complex 7
isolated in 47% (Scheme 3). 
We applied the above conditions to the synthesis of the known dark green cycloruthenate 
complex 9 arising from 2-phenyl pyridine 8. Indeed 2-phenyl pyridine 8 readily reacts in 
methanol with [RuCl2(p-cymene)]2 1 to afford the dark green complex 9 isolated in 94% yield 
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(Scheme 3). This cyclometallate complex 9 was previously prepared by A. Jutand et al. via 
the cyclometallation of 2-phenylpyridine with [RuCl2(p-cymene)]2 in the presence of KOAc 
in CH3CN,
13 and by Davies et al. with an excess of NaOAc in dichloromethane (61%).18b This 
complex 9 is very stable with respect to its analogous complex containing a Ru-OAc bond. 

The reaction of 1-phenylpyrazole 10 with Ru(OAc)2(p-cymene) was studied in details in 
acetonitrile and shown to give at 27°C the orthometallate 
[Ru(OAc)(o-C6H4-2-NNC3H3)(p-cymene)].
14 Thus 1-phenylpyrazole 10 was also reacted with 
[RuCl2(p-cymene)]2 with 4 equiv. KOAc in methanol and the green cyclometallated 
ruthenium(II) complex 11 was formed and isolated in 79% yields (Scheme 3). The complex 
11 was previously prepared by Davies et al. from the reaction of [RuCl2(p-cymene)]2 and 
1-phenylpyrazole in the presence of an excess of NaOAc in dichloromethane (64%).[18d]
Thus the above results show that arenes containing a functional imine group and a 
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nitrogen functional group easily react with [RuCl2(p-cymene)]2 in methanol with 4 equiv of 
KOAc at room temperature to produce isolable cycloruthenate 
[RuCl(o-C6H4-N-heterocycle)(p-cymene)] in a good yield. It contrasts with their ready 
reaction with Ru(OAc)2(p-cymene) which leads to unstable 
[Ru(OAc)(o-C6H4-N-heterocycle)(p-cymene)] complex with labile Ru-OAc bond. These 
reactions definitely point out the key role of acetate or carboxylate in general for the 
deprotonation of ortho arene C-H bonds. 
3.3 Characterization of the Ru(II)-cyclometallated complexes 
The 1H NMR spectrum of 3a shows the cyclometallated phenyl H6 and H3 protons as two 
inequivalent doublets at  = 8.20 ppm and  = 7.54 ppm, respectively, and that the CH=N 
proton gives a singlet at  = 8.10 ppm. (Fig. 1) The isopropyl group of the p-cymene is 
observed as two inequivalent doublets at  = 0.85 ppm and at  = 0.99 ppm, and the four 
aromatic protons of the p-cymene are observed as inequivalent doublets between  = 4.83 and 
5.49 ppm as expected for a p-cymene ligand in a chiral-at-metal Ru-(II) complex centre. 
?
The 1H NMR spectra of ruthenium complexes 3b and 3c are similar to that of 3a except 
that the phenyl H6 proton was observed as a doublet at  = 7.71 ppm or  = 8.15 ppm for 3b or 
3c, respectively. The H4 and H3 protons were observed as two doublets at  = 6.54 ppm and 
= 7.46 ppm for 3b, at  = 7.21 ppm and  = 7.43 ppm for 3c. The 1H NMR spectrum of 
ruthenium complex 3d is similar to that of 3a except that the C-CH3 protons in p-cymene 
were observed as a singlet at  = 2.27 ppm. 
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The 1H NMR spectrum of complex 5 clearly shows that coordination and cyclometallation 
of the ligand has occurred. The CH2-N protons and CH2-O protons were observed as 
multiplets between  = 4.08 and  = 4.78 ppm. The H6 proton was observed as a doublet at  = 
8.14 ppm. The 1H NMR spectrum of complex 7 shows for the H2 proton a doublet at  = 9.46 
ppm. The 1H NMR spectrum of complex 9 showed that the CH=N proton is shifted to a lower 
field at  = 9.20 ppm as compared to that of the free ligand  = 8.72 ppm. The signals for the 
p-cymene ligand in complexes 5, 7, 9, and 11 revealed that they are coordinated in a chiral 
ruthenium complex.  
In the 13C NMR spectra, the expected number of carbons can be seen and the metallated 
carbon atoms of cyclometallated ruthenium(II) imine complexes 3a-3d are observed at 189.2, 
191.5, 190.5 and 188.3 ppm, respectively, at more lower field than that of cyclometallated 
ruthenium(II) heterocycle complexes 5, 7, 9 and 11 (182.7, 178.4, 181.5 and 161.9 ppm).The 
CH=N carbon of complexes 3a, 3b, 3c are observed at 8.10, 7.97 and 8.06 pm, respectively. 
The v(C=N) free imine of 2a absorption at 1621 cm-1 decreases to 1579 cm-1 as expected by 
coordination of the aryl aldimine nitrogen in complex 3a. 
3.4 X-ray structure analysis of complexes 3a, 3b and 7. 
Crystal of 3a, 3b and 7, obtained from EtOH/EtOAc solvents, were suitable for X-ray 
diffraction. The ORTEP view of complexes 3a, 3b and 7 are shown in Fig. 2. 
The summary of the data collection and refinement parameters are given in Table 1
whereas selected bond lengths and bond angles are given in Table 2. Each of the structure of 
3a, 3b and 7 shows the expected piano stool geometry. As to be seen in Table 1, the Ru-Cl 
bond lengths of imine complexes 3a and 3b (2.4161(4) Å and 2.4183(6) Å) appeared slightly 
longer than that of benzo[h]quinoline complex 7 (2.3999(11) Å), and the same observation 
was made for the Ru-C bond lengths. However the Ru-N bonds of imine complexes 3a and 
3b (2.1115(15) Å and 2.0966(19) Å) are longer than that of complex 7 (2.0883(3) Å). On the 
other hand, the chelate bite angles C-Ru-Cl and Cl-Ru-N appear slightly larger in more 
flexible arylimine cyclometallated ruthenium(II) complexes 3a and 3b than for the rigid 
cyclometallated benzo[h]quinoline in complex 7 (Table 1). 
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3a                                       3b 
                                     7 
Fig. 2 Molecular structure and atom numbering scheme for 3a, 3b and 7 with 50% 
displacement ellipsoids, all H atoms are omitted for clarity.  
Table 1. Selected bond distances and angles of complexes 3a, 3b and 7
Complex bond distances (Å) angles (o) 
Ru-C Ru-N Ru-Cl C-Ru-N C-Ru-Cl Cl-Ru-N 
3a 2.0463(17) 2.1115(15) 2.4161(4) 77.75(6) 87.54(5) 87.96(4) 
3b 2.048(2) 2.0966(19) 2.4183(6) 77.94(8) 85.80(6) 86.39(5) 
7 2.054(4) 2.088(3) 2.3999(11) 78.97(15) 83.98(11) 86.37(11) 
Table 2. Crystallographic data for 3a, 3b and 7 
Complex 3a 3b 7 
Empirical formula C24H26ClNRu C25H28ClNORu C23H22ClNRu 
Formula weight 464.98 495.00 448.94 
T (K) 150(2) 150(2) 150(2) 
(Å) 0.71073 0.71073 0.71073 
Crystal system Monoclinic Monoclinic Orthorhombic 
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Color, habit Orange, prism Orange, prism Orange, prism 
Crystal size (mm) 0.58×0.29 × 0.17 0.47 × 0.43 × 0.26 0.43 × 0.15 × 0.08 
Space group P 21/n P 21/n P c a b 
a (Å) 10.9423(3) 11.7681(12) 7.9390(17) 
b (Å) 8.1961(2) 7.7852(9) 14.829(2) 
c (Å) 23.3753(7) 25.379(3) 31.719(5) 
 (o) 90 90 90 
 (o) 102.0690(10) 103.000(5) 90 
 (o) 90 90 90 
V (Å3) 2050.06(10) 2265.6(4) 3734.2(11) 
Z 4 4 8 
Absorption coefficient 
(mm-1) 
0.903 0.825 0.989 
 range (o) 3.13-27.47 3.09-27.41 2.91-27.48 
Index range -14h11, -10k9, 
-27l30 
-13h15, -9k10, 
-32l21 
-10h6, -19k17, 
-41l40 
Reflections collected 15025 16551 16104 
Independent 
reflections (Rint) 
4670 (0.0304) 5114 (0.0520) 4167 (0.0478) 
Data/restraints/parame
ters 
4670 / 0 / 248 5114 / 0 / 267 4167 / 0 / 238 
Goodness-of-fit on F2 1.032 0.959 1.113 
Final R indices 
[I>2	(I)] 
R1=0.0230, 
wR2=0.0538 
R1=0.0291, 
wR2=0.0715 
R1=0.0468, 
wR2=0.0974 
R indices (all data) R1=0.0262, 
wR2=0.0553 
R1=0.0324, 
wR2=0.0735 
R1=0.0584, 
wR2=0.1023 
Largest diff. peak and 
hole (e. Å3) 
0.451 and -0.399 0.416 and -0.581 2.024 and -1.231 
3.5 One pot Ru(II) cyclometallation of 1-phenylpyrazole and alkyne insertion 
The insertion of an alkyne into a cycloruthenate Ru-C bond is not straightforward, 18a thus we 
attempted the direct reaction of the heterocycle 10 with complex 1 and KOAc, under the 
cyclometallation formation conditions but in the presence of one equivalent of 
diphenylacetylene in methanol. This reaction led directly to the formation of the complex 12 , 
which was isolated in 67% yield after 20 h at room temperature, and corresponds to the 
insertion product of the alkyne into the cyclometallated C-Ru bond of intermediate 11, 
(Scheme 4). This complex was previously obtained by Davies by insertion of 
diphenylacetylene into the complex 11 and obtained in 42%.18a Our results in Scheme 4 show 
that alkyne insertion complex can be synthesized more efficiently directly from 
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phenylpyrazole, alkyne and ruthenium complex 1 than via two steps : the cyclometallation 
followed by the alkyne insertion.18a Whereas in 13C NMR  the (C1-Ru) carbon singlet of 11 is 
at δ 161.9 ppm, for the new cyclometallated complex 12 the =C(Ph)-Ru carbon atom appears 
as a singlet at δ = 183.3 ppm. It is suggested that the alkyne insertion takes place on reaction 
with the in situ generated Ru-OAc containing intermediate, analogous to 11, instead of 
insertion into the Ru-C bond of the 18 electrons complex 11. The easy Ru-OAc bond 
dissociation should allow the alkyne coordination and insertion, before final exchange of the 
acetate by chloride leading to the stable Ru-Cl bond and complex 12.  
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3.6 From stoichiometric to catalytic diarylation of aryl imines 
The synthesis of cyclometallated ruthenium(II) imine complexes 3 after ortho C-H bond 
activation via C-H deprotonation led us to search for the functionalization of the (Ru-C) 
carbon of a cyclometallated aryl imine with aryl halide. First we showed that the reaction of 
cyclometallated ruthenium(II) complex 3a with 2 equiv. of arylbromide required the presence 
of acetate and thus the reaction was performed in the presence of 2 equiv. of KOAc, 2 equiv. 
of K2CO3 in NMP at 130
oC for 24 h. Under these conditions 85% GC-yield of mixed-arylated 
imines were formed with the ratio of mono-/di- arylated compound of 60:40. (Scheme 5) 

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Scheme 5 Reaction of cyclometallated complex 3a with phenyl bromid
Based on this result, we have searched for the direct catalytic diarylation of imine 2a with 
phenyl bromide by using in situ generated ruthenium(II)-carboxylate catalyst (Table 3). 
Whereas [RuCl2(p-cymene)]2 1 alone in NMP at 120 °C for 48 h gives as expected a low 
conversion of 45%, the ruthenium complex 1 with 2 equiv. KOAc per Ru atom leads to 85 % 
conversion  (Table 3, entries 1, 2). With in situ prepared Ru(OAc)2(p-cymene)
10a,b in NMP 
the reaction needed to be performed at 160 °C for 48 h to reach complete diarylation (entry 
3,4, 5) and the diarylated imine 14 was isolated in 75 % yield (entry 4). NMP appeared to be 
the best solvent for this transformation as DMAc and DCE could not improve the conversion 
into diarylated imine 14 under similar conditions (entries 6, 7). The above observations led us 
to explore favourable conditions and scope for catalytic diarylation of aryimines.20 
Table 3 Optimisation for the direct arylation of aldimine 2a with Ru(II)/KOAc catalytic 
system.
[a]

Entry Solvent Additives 
(mol%) 
Time  
(h) 
Temp (°C) Conv. 
(%)b
Mono/di 
13/14
1 NMP - 48 120 45 14:86 
2 NMP KOAc(20) 48  85 15:85 
3 NMP KOAc(20) 48 140 
 

4 NMP KOAc(20) 48 160 100(75)c 0:100 
5 NMP KOAc(20) 24  50 
6 DMAc KOAc(20) 48 160 88 15:85 
7 DCE KOAc(20) 48 120 20 40:60 
[a] Imine (0.5 mmol), PhBr (1.25 mmol), [RuCl2(p-cymene)]2 (5 mol%), additives, 3 equiv K2CO3, solvent 
(2 mL), 10 µL of tetradecane as the internal standard. [b] Conversion of imine. [c] in parenthesis, isolated 
yields of purified purified diarylated product 14. 
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4 Conclusion 
We have described the easy preparation of new cyclometallated N-containing ruthenium(II) 
complexes especially derivatives of aryl imines, 2-phenyl oxazoline, benzo[h]quinoline and 
the improved synthesis of cycloruthenate derivatives of 2-phenylpyridine and 
1-phenylpyrazole via C-H bond activation via deprotonation simply with KOAc at room 
temperature in methanol. X-ray struture analysis of complexes 3a, 3b and 7 comfirmed the 
struture of the cyclic N-Ru-C complexes and show the expected piano stool geometry and 
chirality-at-metal of the complexes. We have shown the efficient diect catalytic diarylation of 
an arylimine by arylbromide promoted by the association of [RuCl2(p-cymene)]2 with 4 equiv. 
of KOAc, shown before to afford the Ru(OAc)2(p-cymene) catalyst. 
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crystallographic data for this paper. These data can be obtained free of charge from 
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Highlights 
Room temperature  (N-Ru-C)-cycloruthenation  of arylimines. 
Key role of acetate for C-H bond activation/deprotonation.  
Ru-Cl remaining bond is crucial for cycloruthenate  isolation.  
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